S&P Global Inc.
For the period ended Dec 31, 2023. Filed Feb 9, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 9, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Taxes on Income
- Taxes on Income
Income before taxes on income resulting from domestic and foreign operations is as follows:
| (in millions) | Year Ended December 31, | ||
|---|---|---|---|
| 2023 | 2022 | 2021 | |
| Domestic operations | $1,899 | $3,426 | $2,874 |
| Foreign operations | 1,772 | 1,276 | 1,290 |
| Total income before taxes | $3,671 | $4,702 | $4,164 |
The provision for taxes on income consists of the following:
| (in millions) | Year Ended December 31, | ||
|---|---|---|---|
| 2023 | 2022 | 2021 | |
| Federal: | |||
| Current | $559 | $928 | $438 |
| Deferred | (177) | (185) | (9) |
| Total federal | 382 | 743 | 429 |
| Foreign: | |||
| Current | 370 | 322 | 295 |
| Deferred | (150) | (98) | 23 |
| Total foreign | 220 | 224 | 318 |
| State and local: | |||
| Current | 216 | 265 | 153 |
| Deferred | (40) | (52) | 1 |
| Total state and local | 176 | 213 | 154 |
| Total provision for taxes | $778 | $1,180 | $901 |
A reconciliation of the U.S. federal statutory income tax rate to our effective income tax rate for financial reporting purposes is as follows:
| Year Ended December 31, | |||
|---|---|---|---|
| 2023 | 2022 | 2021 | |
| U.S. federal statutory income tax rate | 21.0% | 21.0% | 21.0% |
| State and local income taxes | 3.5 | 3.9 | 3.3 |
| Foreign operations | (5.1) | (2.8) | (0.2) |
| Stock-based compensation | (0.4) | — | (0.8) |
| S&P Dow Jones Indices LLC joint venture | (1.5) | (1.1) | (1.1) |
| Tax credits and incentives | (2.0) | (1.3) | (2.3) |
| Divestitures | 1.8 | 2.9 | — |
| Other, net | 3.9 | 2.5 | 1.7 |
| Effective income tax rate | 21.2% | 25.1% | 21.6% |
Fluctuation in tax rates by year is primarily due to tax charge on merger related divestitures and change in mix of income by jurisdiction.
We have elected to recognize the tax on Global Intangible Low Taxed Income (“GILTI”) as a period expense in the year the tax is incurred. GILTI expense is included in Other, net above.
The principal temporary differences between the accounting for income and expenses for financial reporting and income tax purposes are as follows:
| (in millions) | December 31, | |
|---|---|---|
| 2023 | 2022 | |
| Deferred tax assets: | ||
| Accrued expenses | $249 | $179 |
| Loss carryforwards | 495 | 537 |
| Research & Development Expenditures | 258 | 136 |
| Other | 473 | 476 |
| Total deferred tax assets | 1,475 | 1,328 |
| Deferred tax liabilities: | ||
| Goodwill and intangible assets | (4,573) | (4,864) |
| Other | (212) | (174) |
| Total deferred tax liabilities | (4,785) | (5,038) |
| Net deferred income tax asset before valuation allowance | (3,310) | (3,710) |
| Valuation allowance | (316) | (274) |
| Net deferred income tax liability | $(3,626) | $(3,984) |
| Reported as: | ||
| Non-current deferred tax assets | $64 | $81 |
| Non-current deferred tax liabilities | (3,690) | (4,065) |
| Net deferred income tax liability | $(3,626) | $(3,984) |
We record valuation allowances against deferred income tax assets when we determine that it is more likely than not that such deferred income tax assets will not be realized based upon all the available evidence. The valuation allowance is primarily related to operating losses.
As of December 31, 2023, we have approximately$7.1 billion of undistributed earnings of our foreign subsidiaries, of which$4.3 billion is reinvested indefinitely in our foreign operations. We have not recorded deferred income taxes applicable to undistributed earnings of foreign subsidiaries that are indefinitely reinvested in foreign operations. Quantification of the deferred tax liability, if any, associated with indefinitely reinvested earnings is not practicable.
We made net income tax payments totaling $1,279 million in 2023, $1,555 million in 2022, and $883 million in 2021. As of December 31, 2023, we had net operating loss carryforwards of $1,177 million, of which a significant portion has an unlimited carryover period under current law.
A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:
| (in millions) | Year ended December 31, | ||
|---|---|---|---|
| 2023 | 2022 | 2021 | |
| Balance at beginning of year | $223 | $147 | $121 |
| Additions based on tax positions related to the current year | 21 | 28 | 35 |
| Additions for tax positions of prior years | 10 | 62 | 9 |
| Reduction for settlements | (11) | — | (8) |
| Expiration of applicable statutes of limitations | (13) | (14) | (10) |
| Balance at end of year | $230 | $223 | $147 |
The total amount of federal, state and local, and foreign unrecognized tax benefits as of December 31, 2023, 2022 and 2021 was$230 million, $223 million and $147 million, respectively, exclusive of interest and penalties. During the year ended December 31, 2023, the change in unrecognized tax benefits resulted in a net increase of tax expense of$5 million.
We recognize accrued interest and penalties related to unrecognized tax benefits in interest expense and operating-related expense, respectively. Based on the current status of income tax audits, we believe that the total amount of unrecognized tax benefits on the balance sheet may be reduced by up to approximately$12 million in the next twelve months as a result of the resolution of local tax examinations and expiration of applicable statutes of limitations. In addition to the unrecognized tax benefits, we had accrued interest and penalties associated with unrecognized tax benefits of$50 million and $38 million as of December 31, 2023 and 2022, respectively.
The U.S. federal income tax audits for 2018 through 2023 are in process. During 2023, we completed state and foreign tax audits and, with few exceptions, we are no longer subject to federal, state, or foreign income tax examinations by tax authorities for the years before 2015. The impact to tax expense in 2023, 2022 and 2021 was not material.
We file income tax returns in the U.S. federal jurisdiction and various state and foreign jurisdictions, and we are routinely under audit by many different tax authorities. We believe that our accrual for tax liabilities is adequate for all open audit years based on an assessment of many factors including past experience and interpretations of tax law. This assessment relies on estimates and assumptions and may involve a series of complex judgments about future events. It is possible that tax examinations will be settled prior to December 31, 2024. If any of these tax audit settlements do occur within that period, we would make any necessary adjustments to the accrual for unrecognized tax benefits.
For tax years beginning after December 31, 2021, the Tax Cuts and Jobs Act of 2017 (“TCJA”) requires taxpayers to capitalize and amortize research and development costs pursuant to Internal Revenue Code (“IRC”) Section 174. Section 174 requires taxpayers to capitalize research and development costs and amortize them over 5 years for expenditures attributed to domestic research and 15 years for expenditures attributed to foreign research. This provision affected a significant proportion of the Company for the first time in 2023. During 2023, our cash taxes were adversely impacted by the requirement to capitalize and amortize research and development expenses under Section 174. Although Congress is considering legislation that would reinstate and extend Section 174 expensing for certain research and experimental expenditures, the possibility that this will happen is uncertain.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.